FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914461011> ?p ?o ?g. }

• W2914461011 endingPage "4519" @default.
• W2914461011 startingPage "4511" @default.
• W2914461011 abstract "Interleukin-1 receptor–associated kinase 4 (IRAK4) is a key player in innate immune and inflammatory responses, performing a critical role in signal transduction downstream of Toll-like receptors and interleukin-1 (IL-1) receptors. Upon ligand binding and via its N-terminal death domain, IRAK4 is recruited to an oligomeric receptor that is proximal to the Myddosome signaling complex, inducing IRAK4 kinase domain dimerization, autophosphorylation, and activation. To date, all known IRAK4 structures are in the active conformation, precluding a good understanding of IRAK4’s conformational dynamics. To address this issue, here we first solved three crystal structures of the IRAK4 kinase domain (at ≤2.6 Å resolution), in its unphosphorylated, inactive state bound to either the ATP analog AMP-PNP or to one of the two small-molecule inhibitors JH-I-25 and JH-I-17. The structures disclosed that although the structure in complex with AMP-PNP is in an “αC-out” inactive conformation, those in complex with type I inhibitors assume an active “Asp–Phe–Gly (DFG)-in” and “αC-in” conformation. The ability of unphosphorylated IRAK4 to take on variable conformations prompted us to screen for small-molecule inhibitors that bind preferentially to unphosphorylated IRAK4, leading to the identification of ponatinib and HG-12-6. Solving the structures of unphosphorylated IRAK4 in complex with these two inhibitors, we found that they both bind as type II inhibitors with IRAK4 in a “DFG-out” conformation. Collectively, these structures reveal conformational flexibility of unphosphorylated IRAK4 and provide unexpected insights into the potential use of small molecules to modulate IRAK4 activity in cancer, autoimmunity, and inflammation. Interleukin-1 receptor–associated kinase 4 (IRAK4) is a key player in innate immune and inflammatory responses, performing a critical role in signal transduction downstream of Toll-like receptors and interleukin-1 (IL-1) receptors. Upon ligand binding and via its N-terminal death domain, IRAK4 is recruited to an oligomeric receptor that is proximal to the Myddosome signaling complex, inducing IRAK4 kinase domain dimerization, autophosphorylation, and activation. To date, all known IRAK4 structures are in the active conformation, precluding a good understanding of IRAK4’s conformational dynamics. To address this issue, here we first solved three crystal structures of the IRAK4 kinase domain (at ≤2.6 Å resolution), in its unphosphorylated, inactive state bound to either the ATP analog AMP-PNP or to one of the two small-molecule inhibitors JH-I-25 and JH-I-17. The structures disclosed that although the structure in complex with AMP-PNP is in an “αC-out” inactive conformation, those in complex with type I inhibitors assume an active “Asp–Phe–Gly (DFG)-in” and “αC-in” conformation. The ability of unphosphorylated IRAK4 to take on variable conformations prompted us to screen for small-molecule inhibitors that bind preferentially to unphosphorylated IRAK4, leading to the identification of ponatinib and HG-12-6. Solving the structures of unphosphorylated IRAK4 in complex with these two inhibitors, we found that they both bind as type II inhibitors with IRAK4 in a “DFG-out” conformation. Collectively, these structures reveal conformational flexibility of unphosphorylated IRAK4 and provide unexpected insights into the potential use of small molecules to modulate IRAK4 activity in cancer, autoimmunity, and inflammation." @default.
• W2914461011 created "2019-02-21" @default.
• W2914461011 creator A5012278873 @default.
• W2914461011 creator A5012615258 @default.
• W2914461011 creator A5015056220 @default.
• W2914461011 creator A5022352605 @default.
• W2914461011 creator A5023382223 @default.
• W2914461011 creator A5074563113 @default.
• W2914461011 creator A5077944878 @default.
• W2914461011 creator A5091393843 @default.
• W2914461011 date "2019-03-01" @default.
• W2914461011 modified "2023-10-13" @default.
• W2914461011 title "Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor–associated kinase 4 (IRAK4)" @default.
• W2914461011 cites W1175168914 @default.
• W2914461011 cites W1563798247 @default.
• W2914461011 cites W1765013689 @default.
• W2914461011 cites W1891334654 @default.
• W2914461011 cites W1969939692 @default.
• W2914461011 cites W1970174659 @default.
• W2914461011 cites W1983430176 @default.
• W2914461011 cites W1986191025 @default.
• W2914461011 cites W1989742444 @default.
• W2914461011 cites W1993211211 @default.
• W2914461011 cites W1994787189 @default.
• W2914461011 cites W2001809367 @default.
• W2914461011 cites W2015263036 @default.
• W2914461011 cites W2025367272 @default.
• W2914461011 cites W2033185023 @default.
• W2914461011 cites W2037883542 @default.
• W2914461011 cites W2052221882 @default.
• W2914461011 cites W2066123607 @default.
• W2914461011 cites W2066205838 @default.
• W2914461011 cites W2080601747 @default.
• W2914461011 cites W2086286404 @default.
• W2914461011 cites W2094531358 @default.
• W2914461011 cites W2100794900 @default.
• W2914461011 cites W2103133890 @default.
• W2914461011 cites W2106232004 @default.
• W2914461011 cites W2109491705 @default.
• W2914461011 cites W2110648386 @default.
• W2914461011 cites W2116382435 @default.
• W2914461011 cites W2128307445 @default.
• W2914461011 cites W2132334410 @default.
• W2914461011 cites W2140380015 @default.
• W2914461011 cites W2141040025 @default.
• W2914461011 cites W2144081223 @default.
• W2914461011 cites W2145866317 @default.
• W2914461011 cites W2151993654 @default.
• W2914461011 cites W2156480395 @default.
• W2914461011 cites W2165576062 @default.
• W2914461011 cites W2180229411 @default.
• W2914461011 cites W2242410523 @default.
• W2914461011 cites W2487246818 @default.
• W2914461011 cites W2605980783 @default.
• W2914461011 cites W2613042274 @default.
• W2914461011 cites W4248872320 @default.
• W2914461011 doi "https://doi.org/10.1074/jbc.ra118.005428" @default.
• W2914461011 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6433055" @default.
• W2914461011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30679311" @default.
• W2914461011 hasPublicationYear "2019" @default.
• W2914461011 type Work @default.
• W2914461011 sameAs 2914461011 @default.
• W2914461011 citedByCount "11" @default.
• W2914461011 countsByYear W29144610112020 @default.
• W2914461011 countsByYear W29144610112021 @default.
• W2914461011 countsByYear W29144610112022 @default.
• W2914461011 countsByYear W29144610112023 @default.
• W2914461011 crossrefType "journal-article" @default.
• W2914461011 hasAuthorship W2914461011A5012278873 @default.
• W2914461011 hasAuthorship W2914461011A5012615258 @default.
• W2914461011 hasAuthorship W2914461011A5015056220 @default.
• W2914461011 hasAuthorship W2914461011A5022352605 @default.
• W2914461011 hasAuthorship W2914461011A5023382223 @default.
• W2914461011 hasAuthorship W2914461011A5074563113 @default.
• W2914461011 hasAuthorship W2914461011A5077944878 @default.
• W2914461011 hasAuthorship W2914461011A5091393843 @default.
• W2914461011 hasBestOaLocation W29144610111 @default.
• W2914461011 hasConcept C107824862 @default.
• W2914461011 hasConcept C12554922 @default.
• W2914461011 hasConcept C150109051 @default.
• W2914461011 hasConcept C170493617 @default.
• W2914461011 hasConcept C184235292 @default.
• W2914461011 hasConcept C185592680 @default.
• W2914461011 hasConcept C203014093 @default.
• W2914461011 hasConcept C2777977768 @default.
• W2914461011 hasConcept C2778690821 @default.
• W2914461011 hasConcept C55493867 @default.
• W2914461011 hasConcept C62478195 @default.
• W2914461011 hasConcept C71240020 @default.
• W2914461011 hasConcept C74172505 @default.
• W2914461011 hasConcept C86803240 @default.
• W2914461011 hasConcept C95444343 @default.
• W2914461011 hasConcept C97029542 @default.
• W2914461011 hasConceptScore W2914461011C107824862 @default.
• W2914461011 hasConceptScore W2914461011C12554922 @default.
• W2914461011 hasConceptScore W2914461011C150109051 @default.
• W2914461011 hasConceptScore W2914461011C170493617 @default.
• W2914461011 hasConceptScore W2914461011C184235292 @default.

• next